Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1632 1791
This examiner grants 23% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17598963 | METHODS TO ENHANCE T CELL REGENERATION | Final Rejection | President and Fellows of Harvard College |
| 17286534 | Soluble Extracellular Matrix Composition and Method for Intravascular Delivery | Non-Final OA | The Regents of the University of California |
| 18319265 | METHODS AND ASSAYS FOR ANALYZING SECRETOME-CONTAINING COMPOSITIONS | Final Rejection | FUJIFILM Corporation |
| 17925355 | COMPOSITION FOR ENHANCING IMMUNE RESPONSE BY USING ACTIVATION FUNCTION OF DENDRITIC CELLS OF STROMAL VASCULAR FRACTIONS ISOLATED FROM ADIPOSE TISSUES | Final Rejection | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 19221545 | METHODS FOR DECELLULARIZING HUMAN OMENTUM AND PRODUCTS GENERATED THEREFROM | Final Rejection | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 17617191 | RED BLOOD CELL STORAGE SOLUTIONS, ADDITIVES, AND METHODS FOR IMPROVING THE STORAGE OF RED BLOOD CELLS USING INORGANIC PYROPHOSPHATES | Non-Final OA | University of Cincinnati |
| 17843086 | PERFUSION SYSTEM FOR CORNEAL ENDOTHELIAL CELL GRAFT EVALUATION | Final Rejection | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17626728 | ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 17428593 | PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS | Final Rejection | The General Hospital Corporation |
| 17756398 | THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS | Non-Final OA | University of Pittsburgh - of the Commonwealth System of Higher Education |
| 17420787 | SYSTEM AND METHODS FOR MONITORING ADOPTIVE CELL THERAPY CLONALITY AND PERSISTENCE | Final Rejection | Iovance Biotherapeutics, Inc. |
| 17492137 | METHODS OF PROMOTING THYMIC EPITHELIAL CELL AND THYMIC EPITHELIAL CELL PROGENITOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS, RESULTING CELLS, AND USES THEREOF | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17204147 | Hybrid Thymus, Methods of Making, and Methods of Using to Induce Xenograft Tolerance, Restore Immunocompetence and Thymic Function | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17612142 | Three-Dimensional Cross-Linked Scaffolds Of Peripheral Blood Plasma And Their Use | Final Rejection | SANFORD HEALTH |
| 18288505 | COMPOSITIONS AND METHODS FOR RAPID GENERATION OF MODIFIABLE STABLE CELL LINES | Non-Final OA | Duke University |
| 18924564 | SCALABLE FABRICATION OF A SELF-ASSEMBLED CELL SHEET AND USES THEREOF | Final Rejection | McMaster University |
| 17856653 | STEM CELL FATE ENGINEERING METHODS | Final Rejection | Wisconsin Alumni Research Foundation |
| 18319691 | METHODS OF PRODUCING THREE-DIMENSIONAL CELL TISSUE, AND THREE-DIMENSIONAL CELL TISSUES | Final Rejection | TOPPAN Inc. |
| 18476573 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION | Non-Final OA | Novocure GmbH |
| 17054097 | Combined Purification and Concentration by Deterministic Lateral Displacement With Recirculation of Product | Non-Final OA | ZEON CORPORATION |
| 17992032 | METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 18248739 | METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS | Non-Final OA | Research Development Foundation |
| 18029026 | PARATHYROID GLAND CELLS | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 17458558 | CELL CULTURE AUXILIARY AGENT AND CELL CULTURE MEDIUM USING THE SAME | Final Rejection | 3D GLOBAL BIOTECH INC. |
| 18562797 | EX VIVO HUMAN MODEL INTENDED FOR EVALUATING ALLERGIC OR PSEUDO-ALLERGIC INFLAMMATORY POTENTIAL | Final Rejection | GENOSKIN |
| 17641376 | METHOD OF PRODUCING LYOPHILIZED CELLS | Non-Final OA | LONZA LTD |
| 18263934 | Cell Clusters Comprising Stem and Islet Cells, Methods of Making, and Treatment of Diabetes Mellitus Therewith | Non-Final OA | SYMBIOCELLTECH, LLC |
| 18262894 | BACTERIA PRODUCING GAMMA-AMINOBUTYRIC ACID (GABA) AND USES OF THE BACTERIA | Non-Final OA | Eastern Washington University |
| 17916434 | CULTURE PLATFORMS, METHODS, AND USES THEREOF | Non-Final OA | AALTO UNIVERSITY FOUNDATION SR |
| 18039033 | CULTURE MEDIUM COMPOSITION FOR ESTABLISHING OR CULTURING KERATINOCYTES COMPRISING CALCIUM, EPIDERAL GROWTH FACTOR, AND ALBUMIN | Non-Final OA | XCELL THERAPEUTICS ING. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy